Repligen Corporation RGEN
178.27 USD +5.32 (+3.08%)
At closeNov 3, 2026, 4:02 PM EST
178.27 0.00 0.00%
After hours · Nov 3, 4:02 PM ET
173.00 Day range 181.55
100.99 52-week range 198.87
- YTD
- +8.79%
- 1 year
- +18.71%
Analyst view
Consensus: buy
Buy
Price target (mean) 203.45 +14.1% upside
Now 178.27
- Target (low)
- 175.00
- Target (mean)
- 203.45
- Target (high)
- 235.00
Ratings (0m) 21 17 buy · 4 hold · 0 sell
- Strong buy3
- Buy14
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 21
- 1 month ago 21
- 2 months ago 22
- 3 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.52375 | 0.50 – 0.545 | 0.49 | +6.9% | 241.08M | +21.8% | 17 |
| Next quarter | 0.59514 | 0.53141 – 0.67 | 0.48 | +24.0% | 250.28M | +28.8% | 10 |
| Current year | 2.07 | 2.05 – 2.09 | 1.71 | +21.3% | 848.81M | +15.0% | 19 |
| Next year | 2.65 | 2.47 – 2.92 | 2.07 | +28.0% | 1.07B | +26.1% | 17 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 28, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 19, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 9, 2026 | UBS | Maintained | Buy | Buy |
| Jul 30, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 29, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 7, 2026 | Benchmark | Upgrade | Hold | Buy |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jun 3, 2026 | HSBC | Maintained | Buy | Buy |
| May 6, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| May 6, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 20, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Apr 17, 2026 | Roth Capital | Initiated | — | Buy |
| Apr 14, 2026 | Barclays | Maintained | Overweight | Overweight |
| Apr 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Mar 23, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Feb 25, 2026 | UBS | Maintained | Buy | Buy |
| Feb 25, 2026 | Barclays | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jan 16, 2026 | UBS | Maintained | Buy | Buy |
| Dec 15, 2025 | Barclays | Maintained | Overweight | Overweight |
| Dec 15, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 29, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Oct 29, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 7, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 2, 2025 | Barclays | Maintained | Overweight | Overweight |
| Oct 1, 2025 | HSBC | Initiated | — | Buy |
| Sep 22, 2025 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Sep 12, 2025 | Jefferies | Maintained | Hold | Hold |
